HAE is chronic, unpredictable, and life limiting1

Characterized by recurrent angioedema attacks, hereditary angioedema (HAE) is associated with considerable morbidity1

While all HAE attacks can be debilitating, laryngeal attacks are life threatening and often occur without warning—but the burden of HAE goes beyond just the attack.1,2

Patient burden of hereditary angioedema Patient burden of hereditary angioedema

HAE consensus guidelines state that the overall goals of HAE treatment are to reduce morbidity and mortality, and to restore a normal quality of life to patients.3